NCT01754129View on ClinicalTrials.gov

Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

CompletedOBSERVATIONAL

Enrollment

148

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Parkinson's Disease

All Listed Sponsors

lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01754129 - Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa | Biotech Hunter | Biotech Hunter